NeuroMetrix intends to price public offering of common-share units

Deal finances product commercialization and general corporate purposes

By Devika Patel

Knoxville, Tenn., Nov. 23 - NeuroMetrix, Inc. will price a public offering of its units, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.

The units will consist of common shares and warrants.

Proceeds will be used for general corporate purposes, including commercialization efforts for the company's NC-stat DPNCheck product, for developing Sensus and other product candidates and to invest in securities.

The medical device company has headquarters in Waltham, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.